At Janssen we strive for excellence and, as a partner in hematology, we are committed to delivering high quality medical education whilst providing a platform for knowledge exchange and innovation. To help us achieve this we are privileged to have the support and participation of the internationally renowned experts who form our scientific committee and faculties. Their involvement ensures we continue to provide clinically relevant and balanced education.
The HME- Academy site is an excellent resource for educational materials delivered by internationally respected experts who are leaders in their field. You will find the latest data and thinking on the management of patients across a range of hematological malignancies including Multiple Myeloma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Waldenströms Macroglobulinemia and Acute Myeloid Leukemia.
By clicking on “SEE EXPERT OPINIONS” you will be redirected to the section on disease management and clinical practice opinion, here you will also find information of upcoming events.
The HME-forum is an innovative programme developed with an eminent scientific committee where, through live interactive broadcasts, viewing clinicians can hear experts discuss latest data and its impact on clinical practice. During each roundtable broadcast you will have the opportunity to ask questions of the faculty which will be addressed live.
Once registered for an upcoming broadcast you may also choose to watch the webinar at a more convenient time along with other past broadcasts.
Multiple myeloma is the second-most common hematologic cancer. It is a heterogeneous, relapse-remitting cancer and can follow a complex treatment pathway. Explore this dedicated resource to find the latest information on the pathogenesis, symptoms and diagnosis of multiple myeloma, as well as the latest emerging targets and approaches being used to improve patient outcomes.
The European Hematology Association (EHA) is a non-profit scientific association that represents European medical professionals with an active interest in hematology. EHA was founded in June 1992 and currently has around 4000 members....
The European School of Haematology (ESH) is a not-for-profit institution for the dissemination of information and lifelong learning founded in 1985 to promote and facilitate access to state-of-the-art and cutting-edge knowledge in haematology and related disciplines at the European level.
The EBMT is a not-for-profit medical and scientific organisation established in 1974. It is dedicated to fighting life-threatening blood cancers and diseases and improving patients’ lives...
European Myeloma Network (EMN) represents the major European, international association in multiple myeloma and related conditions where various countries are represented. It is a wide platform that can be used by European investigators to start new trials and collaborative initiatives.
The International Academy for Clinical Hematology (IACH) is founded by an international group of physicians whose focus is to promote good clinical practice in the field of clinical hematology. The IACH aims to create a comprehensive intellectual and operational environment for acquisition of knowledge, skills, clinical judgement, and attitudes essential for the practice of clinical hematology. It is responsible for very successful meetings such as World Congresses on Controversies in Multiple Myeloma (COMy) with more than 5 editions in the past years.
The European Oncology Nursing Society (EONS) is a pan-European organization dedicated to the support and development of cancer nurses. They we engage in projects to help nurses develop their skills, network with each other and raise the profile of cancer nursing across Europe.
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers.